FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "RXQ Compounding, LLC(079640811)" | Dextrose | 500 mg/500 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ephedrine Sulfate | 5 mg/5 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Epinephrine | .01 mg/.01 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Epinephrine | 1 mg/1 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Epinephrine; Lidocaine Hydrochloride | .5 mg/.5 mg; .5 mg/.5 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Epinephrine; Lidocaine Hydrochloride Anhydrous | 10 mg/10 mg; 10 mg/10 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Fentanyl Citrate | .05 mg/.05 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Glutathione | 200 mg/200 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Hydromorphone Hydrochloride | .2 mg/.2 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Hydromorphone Hydrochloride | 1 mg/1 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ketamine Hydrochloride | 10 mg/10 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ketorolac Tromethamine; Tropicamide Hydrochloride; Phenylephrine Hydrochloride; Cyclopentolate Hydrochloride | 3.125 mg/3.125 mg; 3.125 mg/3.125 mg; 3.125 mg/3.125 mg; 3.125 mg/3.125 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Lidocaine Hydrochloride | 10 mg/10 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Lidocaine Hydrochloride | 40 mg/40 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Lidocaine Hydrochloride Anhydrous | 10 mg/10 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Lidocaine Hydrochloride; Tetracaine | 150 mg/150 mg; 150 mg/150 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Lidocaine Hydrochloride; Tetracaine; Epinephrine | 30 mg/30 mg; 30 mg/30 mg; 30 mg/30 mg | 2019-2 | source_no_ndc | 2026-11-14 | ||||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-18 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-59 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-110 | 70004-110-16 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-213 | 70004-213-32 | Fentanyl Citrate | .05 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(037559301)" | 70004-322 | 70004-322-16 | Hydromorphone Hydrochloride | .2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-731 | 70004-731-30 | Magnesium Sulfate Heptahydrate | 2 g | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-440 | 70004-440-12 | Methohexital Sodium | 10 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-411 | 70004-411-56 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-411 | 70004-411-59 | Midazolam Hydrochloride | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-102 | 70004-102-16 | Morphine Sulfate | 2 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-103 | 70004-103-16 | Morphine Sulfate | 5 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-22 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-25 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-16 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-63 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-62 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-100 | 70004-100-18 | Morphine Sulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-750 | 70004-750-09 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-750 | 70004-750-25 | Neostigmine Methylsulfate | 1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-771 | 70004-771-40 | Norepinephrine Bitartrate | .016 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-771 | 70004-771-44 | Norepinephrine Bitartrate | .016 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-774 | 70004-774-40 | Norepinephrine Bitartrate | .032 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-775 | 70004-775-40 | Norepinephrine Bitartrate | .064 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-085 | 70004-085-44 | Oxytocin | 30 [USP'U] | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-084 | 70004-084-46 | Oxytocin | 20 [USP'U] | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-040 | 70004-040-07 | Atropine Sulfate | .4 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-040 | 70004-040-06 | Atropine Sulfate | .4 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-11 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-810 | 70004-810-12 | Phenylephrine Hydrochloride | .1 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-825 | 70004-825-40 | Phenylephrine Hydrochloride | .16 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-816 | 70004-816-12 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-808 | 70004-808-40 | Phenylephrine Hydrochloride | .08 mg/1 mL | 2019-2 | valid | 2026-11-14 | ||
| "SCA Pharmaceuticals, LLC(080545245)" | 70004-811 | 70004-811-40 | Phenylephrine Hydrochloride | .04 mg/1 mL | 2019-2 | valid | 2026-11-14 |